A phase II trial of sorafenib in relapsed and unresectable high-grade osteosarcoma after failure of standard multimodal therapy: An Italian sarcoma group study

G. Grignani, E. Palmerini, P. Dileo, S. D. Asaftei, L. D'ambrosio, Y. Pignochino, M. Mercuri, P. Picci, F. Fagioli, P. G. Casali, S. Ferrari, M. Aglietta

Research output: Contribution to journalArticlepeer-review

Fingerprint

Dive into the research topics of 'A phase II trial of sorafenib in relapsed and unresectable high-grade osteosarcoma after failure of standard multimodal therapy: An Italian sarcoma group study'. Together they form a unique fingerprint.

Medicine & Life Sciences